Skip to main content
Caplight Logo









Renovion, Inc.

Renovion, Inc.

Private
Chapel Hill, North CarolinaHealthcare & Life Scienceshttps://www.renovion.com/

Last Round

VC Round

Apr 3, 2023

Total Funding Raised

$9.15M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Renovion, Inc. is a clinical-stage pharmaceutical company that develops a nebulized therapy to restore mucus clearance and reduce inflammation in the lungs for patients with chronic inflammatory airway diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B2C

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

nebulized therapychronic lung diseaserespiratory therapyBronchiolitis Obliterans SyndromeBOSorphan drugnon-cystic fibrosis bronchiectasisNCFBElung transplant therapymucus clearanceinhalation therapyclinical stage pharmabiopharmaceutical companychronic bronchitisCOPDFDA Fast Trackcystic fibrosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Renovion, Inc. Comparables

Compare Renovion, Inc. with similar companies based on industry and business-model similarity.

Renovion, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aer Therapeutics
86%
Vast Therapeutics
83%
Zambon
78%

Renovion, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 3, 2023
GrantNov 18, 2021
Series AJun 18, 2020
SeedJan 6, 2017

Key People

Founding team and executive leadership

Dan Copeland

CEO

Executive Team

Renovion, Inc. Investors

Notable investors and investment history

Renovion, Inc. investors
InvestorRounds
Onbelay CapitalSeed
KickStart Venture ServicesGrant
First Flight Venture CenterSeed
COPD FoundationVC Round
Leerink PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 281% MoM, reaching 3.9K.

  • Apr 18, 2026

    Monthly visitors increased 48% MoM.

Renovion, Inc. Filings

Explore SEC and related filing metadata, where available.

Renovion, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Renovion, Inc.'s valuation, stock price, and market status.

Is Renovion, Inc. a public or private company?

Renovion, Inc. is a private company.

What is the current stock price of Renovion, Inc.?

Renovion, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Renovion, Inc. worth (valuation)?

Valuation information for Renovion, Inc. is not publicly available.

Can I buy Renovion, Inc. stock?

Renovion, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Renovion, Inc.'s last funding round?

Renovion, Inc.'s most recent funding round was VC Round on April 3, 2023.

Who are the main investors in Renovion, Inc.?

Key investors in Renovion, Inc. include Onbelay Capital, KickStart Venture Services, First Flight Venture Center, COPD Foundation, Leerink Partners.

Will Renovion, Inc. IPO soon?

No public IPO plans have been announced for Renovion, Inc..

How can I track Renovion, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Renovion, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersChapel Hill, North Carolina
Employee Range5
Year Founded2013
Last FundingApr 3, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?